Search images on Google Product Monograph
Active Ingredients:
- insulin degludec, 100 UNIT/ML
- liraglutide, 3.6 MG/ML
DIN: 02474875
Dosage Form(s): SOLUTION
Route(s) of Administration: SUBCUTANEOUS
Description: PRE-FILLED PEN
Schedule: Prescription
Company: NOVO NORDISK CANADA INC – official site
ATC:
- A10 - DRUGS USED IN DIABETES (ATC, WHO, Wiki)
- A10A - INSULINS AND ANALOGUES (ATC, WHO)
- A10AE - Insulins and analogues for injection, long-acting (ATC, WHO)
- A10AE56 - INSULIN DEGLUDEC AND LIRAGLUTIDE (WHO)
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 1X3ML/3X3ML/5X3ML
External Links for Xultophy:
Search on Google
- Xultophy side effects
- Xultophy dosage
- insulin degludec side effects
- insulin degludec dosage
- liraglutide side effects
- liraglutide dosage
Novo Nordisk Canada Inc
Go to Novo Nordisk website to see drug product details. Sometimes you can find xultophy photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.